US FDA approves SetPoint Medical’s novel neuroimmune modulation device, SetPoint System for rheumatoid arthritis: Valencia, California Saturday, August 2, 2025, 17:00 Hrs [IST] ...

The Food and Drug Administration has approved a vagus nerve bioimplant to treat rheumatoid arthritis (RA). The scientific ...

SetPoint Medical's vagus nerve stimulator has received FDA approval for treating moderate-to-severe rheumatoid arthritis (RA) ...

A first-of-its-kind implant has just been granted approval from the US Food and Drug Administration (FDA) for the treatment ...

The agency’s decision was based on the outcomes of the double-blind, randomised, sham-controlled RESET-RA study.

The US Food and Drug Administration has approved a pill-sized device for treating rheumatoid arthritis, marking the first ...

The FDA has approved a medical device that stimulates the vagus nerve for the treatment of moderate-to-severe rheumatoid ...

The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid ...

The SetPoint System consists of a neurostimulation device that is surgically placed under general anesthesia on the vagus nerve.

The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease.

SetPoint Medical announced today that the FDA approved its SetPoint neuroimmune modulation system for treating rheumatoid ...

SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...